Conestoga Small Cap Institutional

Product:  Encompass
Vendor:   Aspire-IPX

Investment Strategy

The investment seeks long-term growth of capital. Under normal market circumstances, the fund invests at least 80% of its net assets in equity securities of small-cap companies. Equity securities include American depositary receipts ("ADRs"), convertible securities, foreign and domestic common and preferred stocks, rights and warrants.



Ticker:
CCALX
Share Class:
Inst
CUSIP:
207019704
Inception Date:
08/13/2014


Investment Expenses, Sales Charges, and Fees

Annual Operating Expense

Net Expense Ratio: 0.90%


Average Annual Total Returns

All average annual total returns are reported net of all fees and as of the end of the last quarter. Past performance does not guarantee future results.


Year 1 3 5 10 Since Inception
(08/13/2014)
Total Returns
-7.35%
-0.10%
9.72%
9.41%
9.83%

Impact of Expenses and Fees

The table below assumes the investor invests $10,000 on the first day of year one and that the original investment earns a continuous 5% return. In addition, it assumes the investor reinvests all earnings, and makes no additional contributions. The 5% rate of return is hypothetical and used only to illustrate the respective impacts of different fee amounts on each investment. It is not intended to predict future investment returns.

Calculations are done by the 403bCompare site in an effort to provide a standardized comparison of the impact of all fees associated with an investment option. This includes all required 403(b) product-level fees, and investment-level fees. For more information on fees or expenses associated with a 403(b) product or investment option, please refer fees located in Help & Resources .


If Shares are Redeemed
End of year
1
5
10
15
20
Total Fees and Charges
$220
$1,126
$2,329
$3,627
$5,041
If Shares are Not Redeemed
End of year
1
5
10
15
20
Total Fees and Charges
$220
$1,126
$2,329
$3,627
$5,041